Uwe Gottschalk appointed as Board Observer Leave a Comment / News / ASolia 15 June 2023 Uwe Gottschalk appointed as Board Observer Read More »
Assaying with iPSC-derived cardiomyocytes: setting the rhythm for early drug discoveryWebinars / ASolia 8 November 2023 – available on demand Assaying with iPSC-derived cardiomyocytes: setting the rhythm for early drug discovery Read More »
Remove the pain, retain the gain: biophysical methods in early drug discoveryWebinars / ASolia 13 June 2023 – available on demand Remove the pain, retain the gain: biophysical methods in early drug discovery Read More »
HiBiT Technology Applications in Protein Secretion, Trafficking and RegulationWebinars / ASolia 7 June 2023 – available on demand HiBiT Technology Applications in Protein Secretion, Trafficking and Regulation Read More »
Jörg Hüser joins Axxam as Chief Scientific Officer Leave a Comment / News / ASolia 1 June 2023 Jörg Hüser joins Axxam as Chief Scientific Officer Read More »
Genedata Screener Open ForumEvents / ASolia 15 June 2023 – London, UK Genedata Screener Open Forum Read More »
Axxam and Promega announce agreement to develop smart assays for drug discovery services Leave a Comment / News / ASolia 23 May 2023 Axxam and Promega announce agreement to develop smart assays for drug discovery services Read More »
Smart assays for TDP43 associated pathologiesWebinars / ASolia 24 May 2023 – available on demand Smart assays for TDP43 associated pathologies Read More »
EWDSy – European Workshop in Drug SynthesisEvents / ASolia 21-24 May 2023 – Siena, Italy EWDSy – European Workshop in Drug Synthesis Read More »
